IHC 2017: Lilly's Lasmiditan Significantly Reduces Pain in Patients with Migraine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. PATH
5. DOCU
6. ASAN
7. CIEN
8. GWRE
9. SPY
10. PL

Go back to IHC 2017: Lilly's Lasmiditan Significantly Reduces Pain in Patients with Migraine
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1159.60 --0 (-0%)
Previous Close $1159.60    52 Week High $88.16 
Open $1159.60    52 Week Low $67.88 
Day High $1159.60    P/E 268.43 
Day Low $1159.60    EPS $4.32 
Volume 45,357